| Preexposure chemoprophylaxis for HIV prevention in men who have sex with men RM Grant, JR Lama, PL Anderson, V McMahan, AY Liu, L Vargas, ... New England Journal of Medicine 363 (27), 2587-2599, 2010 | 5845 | 2010 |
| Preexposure prophylaxis for HIV infection among African women L Van Damme, A Corneli, K Ahmed, K Agot, J Lombaard, S Kapiga, ... New England Journal of Medicine 367 (5), 411-422, 2012 | 1873 | 2012 |
| Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study RM Grant, PL Anderson, V McMahan, A Liu, KR Amico, M Mehrotra, ... The Lancet infectious diseases 14 (9), 820-829, 2014 | 1289 | 2014 |
| Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men PL Anderson, DV Glidden, A Liu, S Buchbinder, JR Lama, JV Guanira, ... Science translational medicine 4 (151), 151ra125-151ra125, 2012 | 1070 | 2012 |
| Effectiveness and safety of oral HIV preexposure prophylaxis for all populations VA Fonner, SL Dalglish, CE Kennedy, R Baggaley, KR O’reilly, ... Aids 30 (12), 1973-1983, 2016 | 1004 | 2016 |
| Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia SG Deeks, T Wrin, T Liegler, R Hoh, M Hayden, JD Barbour, NS Hellmann, ... New England Journal of Medicine 344 (7), 472-480, 2001 | 860 | 2001 |
| Sexual practices and risk of infection by the human immunodeficiency virus: The San Francisco Men's Health Study W Winkelstein, DM Lyman, N Padian, R Grant, M Samuel, JA Wiley, ... Jama 257 (3), 321-325, 1987 | 680 | 1987 |
| Increased production of IL-7 accompanies HIV-1–mediated T-cell depletion: implications for T-cell homeostasis LA Napolitano, RM Grant, SG Deeks, D Schmidt, SC De Rosa, ... Nature medicine 7 (1), 73-79, 2001 | 672 | 2001 |
| Preexposure prophylaxis for HIV infection integrated with municipal-and community-based sexual health services AY Liu, SE Cohen, E Vittinghoff, PL Anderson, S Doblecki-Lewis, O Bacon, ... JAMA internal medicine 176 (1), 75-84, 2016 | 655 | 2016 |
| Time trends in primary HIV-1 drug resistance among recently infected persons RM Grant, FM Hecht, M Warmerdam, L Liu, T Liegler, CJ Petropoulos, ... Jama 288 (2), 181-188, 2002 | 594 | 2002 |
| Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome KS Erlich, J Mills, P Chatis, GJ Mertz, DF Busch, SE Follansbee, RM Grant, ... New England Journal of Medicine 320 (5), 293-296, 1989 | 570 | 1989 |
| Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors FM Hecht, RM Grant, CJ Petropoulos, B Dillon, MA Chesney, H Tian, ... New England Journal of Medicine 339 (5), 307-311, 1998 | 569 | 1998 |
| HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy SG Deeks, FM Hecht, M Swanson, T Elbeik, R Loftus, PT Cohen, ... Aids 13 (6), F35-F43, 1999 | 510 | 1999 |
| A tale of two futures: HIV and antiretroviral therapy in San Francisco SM Blower, HB Gershengorn, RM Grant Science 287 (5453), 650-654, 2000 | 466 | 2000 |
| Decline in HIV infectivity following the introduction of highly active antiretroviral therapy TC Porco, JN Martin, KA Page-Shafer, A Cheng, E Charlebois, RM Grant, ... Aids 18 (1), 81-88, 2004 | 432 | 2004 |
| Activation of virus replication after vaccination of HIV-1-infected individuals. SI Staprans, BL Hamilton, SE Follansbee, T Elbeik, P Barbosa, RM Grant, ... The Journal of experimental medicine 182 (6), 1727-1737, 1995 | 383 | 1995 |
| Sustained CD4+ T Cell Response after Virologic Failure of Protease Inhibitor-Based Regimens in Patients with Human Immunodeficiency Virus Infection SG Deeks, JD Barbour, JN Martin, MS Swanson, RM Grant The Journal of infectious diseases 181 (3), 946-953, 2000 | 368 | 2000 |
| High levels of adherence do not prevent accumulation of HIV drug resistance mutations DR Bangsberg, ED Charlebois, RM Grant, M Holodniy, SG Deeks, S Perry, ... Aids 17 (13), 1925-1932, 2003 | 347 | 2003 |
| Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial L Peterson, D Taylor, R Roddy, G Belai, P Phillips, K Nanda, R Grant, ... PLoS clinical trials 2 (5), e27, 2007 | 341 | 2007 |
| Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised … KH Mayer, JM Molina, MA Thompson, PL Anderson, KC Mounzer, ... The Lancet 396 (10246), 239-254, 2020 | 339 | 2020 |
